BiomX annual free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
BiomX Free Cash Flow (FCF) History (PHGE)
BiomX reported −$26.4M in free cash flow for fiscal 2025, an increase of $10.6M from the previous fiscal year.
View full BiomX company overviewBiomX free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$26.4M | $10.6M | — | — |
| 2024 | 2024-12-31 | −$37.0M | −$15.7M | — | — |
| 2023 | 2023-12-31 | −$21.3M | $7.9M | — | — |
| 2022 | 2022-12-31 | −$29.2M | $2.1M | — | — |
| 2021 | 2021-12-31 | −$31.3M | −$5.8M | — | — |
| 2020 | 2020-12-31 | −$25.5M | −$6.6M | — | — |
| 2019 · Dec 31 | 2019-12-31 | −$18.9M | −$7.4M | — | — |
| 2018 | 2018-12-31 | −$11.4M | — | — | — |
BiomX quarterly free cash flow
Q1.19
Q4.19
Q1.20
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q3.24
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2024 | 2024-09-30 | −$8.1M | −$3.1M | — | — |
| Q4 2023 | 2023-12-31 | −$6.2M | $951,000 | — | — |
| Q3 2023 | 2023-09-30 | −$6.0M | −$472,000 | — | — |
| Q2 2023 | 2023-06-30 | −$4.1M | $5.1M | — | — |
| Q1 2023 | 2023-03-31 | −$5.1M | $2.3M | — | — |
| Q4 2022 | 2022-12-31 | −$7.2M | $2.0M | — | — |
| Q3 2022 | 2022-09-30 | −$5.5M | $1.5M | — | — |
| Q2 2022 | 2022-06-30 | −$9.1M | −$1.9M | — | — |
| Q1 2022 | 2022-03-31 | −$7.4M | $447,000 | — | — |
| Q4 2021 | 2021-12-31 | −$9.2M | −$1.7M | — | — |
| Q3 2021 | 2021-09-30 | −$7.0M | −$884,000 | — | — |
| Q2 2021 | 2021-06-30 | −$7.2M | −$2.5M | — | — |
| Q1 2021 | 2021-03-31 | −$7.8M | −$700,000 | — | — |
| Q4 2020 | 2020-12-31 | −$7.5M | $4.2M | — | — |
| Q3 2020 | 2020-09-30 | −$6.1M | −$5.6M | — | — |
| Q2 2020 | 2020-06-30 | −$4.7M | −$1.2M | — | — |
| Q1 2020 · Mar 31 | 2020-03-31 | −$7.1M | −$4.0M | — | — |
| Q4 2019 | 2019-12-31 | −$11.7M | — | — | — |
| Q1 2020 · Sep 30 | 2019-09-30 | −$490,856 | — | — | — |
| Q4 2019 | 2019-06-30 | −$3.5M | — | — | — |
| Q1 2019 · Mar 31 | 2019-03-31 | −$3.2M | — | — | — |
BiomX free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$25.5M to −$26.4M, a net decrease of $936,000. BiomX's latest reported quarter, Q3 2024, generated −$8.1M in free cash flow, a decrease of $3.1M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review BiomX filings at SEC.gov ↗